Your browser doesn't support javascript.
loading
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Lee, Ivan T; Cosgrove, Catherine A; Moore, Patrick; Bethune, Claire; Nally, Rhiannon; Bula, Marcin; Kalra, Philip A; Clark, Rebecca; Dargan, Paul I; Boffito, Marta; Sheridan, Ray; Moran, Ed; Darton, Thomas C; Burns, Fiona; Saralaya, Dinesh; Duncan, Christopher J A; Lillie, Patrick J; San Francisco Ramos, Alberto; Galiza, Eva P; Heath, Paul T; Girard, Bethany; Parker, Christy; Rust, Dondi; Mehta, Shraddha; de Windt, Elizabeth; Sutherland, Andrea; Tomassini, Joanne E; Dutko, Frank J; Chalkias, Spyros; Deng, Weiping; Chen, Xing; Feng, Jing; Tracy, LaRee; Zhou, Honghong; Miller, Jacqueline M; Das, Rituparna.
Afiliação
  • Lee IT; Moderna, Cambridge, MA, USA. Electronic address: ivan.lee@modernatx.com.
  • Cosgrove CA; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Moore P; Adam Practice, Poole, UK; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bethune C; University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Nally R; Wansford and Kings Cliffe Practice, Wansford, UK.
  • Bula M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
  • Kalra PA; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • Clark R; Layton Medical Centre, Blackpool, UK.
  • Dargan PI; Guy's & St Thomas' NHS Foundation Trust, King's College London, London, UK.
  • Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; Department of Infectious Disease, Imperial College London, London, UK.
  • Sheridan R; Royal Devon University Hospital, Exeter, UK.
  • Moran E; Southmead Hospital, Bristol, UK.
  • Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Burns F; Royal Free London NHS Foundation Trust University and University College London, London, UK.
  • Saralaya D; National Institute for Health Research Patient Recruitment Centre, Bradford, UK; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Duncan CJA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Lillie PJ; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
  • San Francisco Ramos A; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Galiza EP; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Heath PT; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Girard B; Moderna, Cambridge, MA, USA.
  • Parker C; Moderna, Cambridge, MA, USA.
  • Rust D; Moderna, Cambridge, MA, USA.
  • Mehta S; Moderna, Cambridge, MA, USA.
  • de Windt E; Moderna, Cambridge, MA, USA.
  • Sutherland A; Moderna, Cambridge, MA, USA.
  • Tomassini JE; Moderna, Cambridge, MA, USA.
  • Dutko FJ; Moderna, Cambridge, MA, USA.
  • Chalkias S; Moderna, Cambridge, MA, USA.
  • Deng W; Moderna, Cambridge, MA, USA.
  • Chen X; Moderna, Cambridge, MA, USA.
  • Feng J; Moderna, Cambridge, MA, USA.
  • Tracy L; Moderna, Cambridge, MA, USA.
  • Zhou H; Moderna, Cambridge, MA, USA.
  • Miller JM; Moderna, Cambridge, MA, USA.
  • Das R; Moderna, Cambridge, MA, USA.
Lancet Infect Dis ; 23(9): 1007-1019, 2023 09.
Article em En | MEDLINE | ID: mdl-37348519

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article